MANILA, Philippines — A COVID-19 vaccine from another Chinese drugmaker passed the evaluation of the country’s vaccine experts panel, making it the second Chinese COVID-19 vaccine to advance in the application for a clinical trial.
Dr. Jaime Montoya, executive director of the Department of Science and Technology’s Council for Health Research and Development, said Clover Biopharmaceuticals from China has passed the technical review of the Philippines’ vaccine expert panel.
Their application was then submitted to the Ethics Review Board for evaluation and the Food and Drug Administration before it can conduct a clinical trial in the country.
The first vaccine to pass the vac…
Keep on reading: 2nd China COVID-19 vaccine passes PH panel review